These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22454901)

  • 1. Ro 3-4787, a new β-adrenoceptor blocking agent: Studies in normal volunteers.
    Kilborn JR; Turner P
    Br J Clin Pharmacol; 1974 Apr; 1(2):143-9. PubMed ID: 22454901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.
    Thuillez C; Richer C; Duhazé P; Bergougnan L; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 29(4):405-11. PubMed ID: 3912184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of concomitant administration of beta-adrenoceptor blocker and agonist in normal subjects: characterization by heart rate response to exercise. Effects of beta-blocker combined with beta-agonist.
    Karita M; Sato H; Koretsune Y; Imai K; Ozaki H; Yokoyama H; Hori M; Takeda H; Inoue M; Kamada T
    Eur J Clin Pharmacol; 1995; 48(6):467-71. PubMed ID: 8582465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A; Palm D; Pitschner HF; Belz GG
    Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.
    Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL
    Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
    Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
    Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
    Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
    Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
    Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
    Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.
    Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM
    Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade.
    Kumana CR; Kaye CM; Leighton M; Marlin GE
    Eur J Clin Pharmacol; 1977 Aug; 12(1):7-13. PubMed ID: 332505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ro 31-1118, a new cardioselective beta-adrenoceptor antagonist. Pharmacokinetics and effects on heart rate and blood pressure in mild hypertensives.
    Jamieson M; Petrie JC; Webster J; Miller A; Harris RI; Francis RJ
    Eur J Clin Pharmacol; 1985; 29(4):395-9. PubMed ID: 2868899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol.
    Czendlik CH; Sioufi A; Preiswerk G; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):451-9. PubMed ID: 9342580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
    Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.